Fingerprint
Dive into the research topics of 'The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis
Thomas S. Griffith, Troy J. Kemp
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations